Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck

Laryngoscope

Volumn 115, Issue 8, 2005, Pages 1371-1375

  Gourin, Christine G ^a   McAfee, William J ^a   Neyman, Kimberly M ^a   Howington, Jed W ^a   Podolsky, Robert H ^a   Terris, David J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Comorbidity; Head and neck neoplasms; Quality of life; Squamous cell cancer; Treatment

Indexed keywords

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMORBIDITY; FEMALE; HEAD AND NECK CARCINOMA; HEAD AND NECK SURGERY; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; MALE; MOUTH CARCINOMA; MULTIMODALITY CANCER THERAPY; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; PATIENT SATISFACTION; PROBABILITY; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SICKNESS IMPACT PROFILE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 23344445463     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000167983.32017.64     Document Type: Review

References (15)

1. Singh B, Bhaya M, Zimbler M, et al. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma. Head Neck 1998;20:1-7.
2. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope 2000;110:593-602.
3. Singh B, Bhaya M, Stern J, Roland JT, et al. Validation of the Charlson Comorbidity Index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 1997;107:1469-1475.
4. Chen AY, Matson LK, Roberts D, Goepfert H. The significance of comorbidity in advanced laryngeal cancer. Head Neck 2001;23:566-572.
5. Borggreven PA, Kuik DJ, Quak JJ, et al. Comorbid condition as a prognostic factor for complications in major surgery of the oral cavity and oropharynx with microvascular soft tissue reconstruction. Head Neck 2003;25:808-815.
6. Terrell JE, Ronis DL, Fowler KE, et al. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130:401-408.
7. Hall SF, Rochon PA, Streiner DL, et al. Measuring comorbidity in patients with head and neck cancer. Laryngoscope 2002;112:1988-1996.
8. Weymuller EA Jr., Yueh B, Deleyiannis FW, et al. Quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2000;126:329-335.
9. List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head and neck cancer patients. Cancer 1990;66:564-569.
10. Piccirillo JF, Wells CK, Sasaki CT, Feinstein AR. New clinical severity staging system for cancer of the larynx: five-year survival rates. Ann Otol Rhinol Laryngol 1994;103:83-92.
11. Machtay M, Rosenthal DI, Algazy KM, et al. Pilot study of organ preservation multimodality therapy for locally advanced resectable oropharyngeal carcinoma. Am J Clin Oncol 2000;23:509-515.
12. Pfister DG, Shaha AR, Harrison LB. The role of chemotherapy in the curative treatment of head and neck cancer. Surg Oncol Clin North Am 1997;6:749-768.
13. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-2098.
14. Gillespie MB, Brodsy MB, Day TA, Lee F, Martin-Harris B. Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope 2004;114:1362-1367.
15. Deleyiannis FW, Weymuller EA, Coltrera MD. Quality of life of disease-free survivors of advanced (stage III or IV) oropharyngeal cancer. Head Neck 1997;19:466-473.